Filing Details
- Accession Number:
- 0001209191-22-045421
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-11 16:19:35
- Reporting Period:
- 2022-08-11
- Accepted Time:
- 2022-08-11 16:19:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1805890 | Fusion Pharmaceuticals Inc. | FUSN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643085 | Steven Gannon | C/O Fusion Pharmaceuticals, Inc. 2 International Place, Suite 2310 Boston MA 02110 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-11 | 44,400 | $2.03 | 56,400 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
